Goldman Sachs’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.45M Buy
1,056,218
+63,087
+6% +$238K ﹤0.01% 4048
2025
Q4
$4.19M Sell
993,131
-730,847
-42% -$3.57M ﹤0.01% 3904
2025
Q3
$10.3M Buy
1,723,978
+301,180
+21% +$1.47M ﹤0.01% 2935
2025
Q2
$6.03M Buy
1,422,798
+678,895
+91% +$3.29M ﹤0.01% 3226
2025
Q1
$3.27M Buy
743,903
+29,099
+4% +$138K ﹤0.01% 3760
2024
Q4
$3.04M Buy
714,804
+311,990
+77% +$1.53M ﹤0.01% 3940
2024
Q3
$2.37M Buy
402,814
+304,953
+312% +$1.81M ﹤0.01% 4003
2024
Q2
$452K Buy
+97,861
New +$620K ﹤0.01% 4886
2024
Q1
Sell
-28,387
Closed -$135K 5523
2023
Q4
$135K Buy
28,387
+11,659
+70% +$56.2K ﹤0.01% 5242
2023
Q3
$97.9K Sell
16,728
-110,203
-87% -$641K ﹤0.01% 5186
2023
Q2
$679K Buy
126,931
+53,462
+73% +$315K ﹤0.01% 4574
2023
Q1
$512K Sell
73,469
-98,076
-57% -$858K ﹤0.01% 4814
2022
Q4
$1.58M Sell
171,545
-15,085
-8% -$180K ﹤0.01% 4110
2022
Q3
$2.28M Buy
186,630
+125,785
+207% +$1.85M ﹤0.01% 3866
2022
Q2
$803K Buy
60,845
+44,997
+284% +$1.13M ﹤0.01% 4776
2022
Q1
$634K Buy
15,848
+10,964
+224% +$464K ﹤0.01% 5169
2021
Q4
$264K Sell
4,884
-162
-3% -$10.9K ﹤0.01% 5739
2021
Q3
$349K Sell
5,046
-64,749
-93% -$4.6M ﹤0.01% 5408
2021
Q2
$6.31M Buy
69,795
+40,869
+141% +$3.54M ﹤0.01% 3130
2021
Q1
$2.69M Buy
28,926
+12,173
+73% +$1.36M ﹤0.01% 3690
2020
Q4
$1.39M Buy
16,753
+3,214
+24% +$234K ﹤0.01% 3981
2020
Q3
$629K Buy
13,539
+5,559
+70% +$528K ﹤0.01% 4358
2020
Q2
$991K Sell
7,980
-13,141
-62% -$1.5M ﹤0.01% 3960
2020
Q1
$2.3M Buy
21,121
+11,009
+109% +$1.97M ﹤0.01% 3201
2019
Q4
$2.62M Buy
10,112
+4,444
+78% +$1.66M ﹤0.01% 3459
2019
Q3
$2.99M Sell
5,668
-800
-12% -$593K ﹤0.01% 3241
2019
Q2
$6.07M Buy
6,468
+2,938
+83% +$2.95M ﹤0.01% 2721
2019
Q1
$3.84M Sell
3,530
-99
-3% -$88.5K ﹤0.01% 3194
2018
Q4
$2.16M Buy
+3,629
New +$2.68M ﹤0.01% 3480

Other funds holding ACB

Goldman Sachs's ACB Position: Q1 2026 in Review

Goldman Sachs increased its Aurora Cannabis (ACB) stake by 6.4% in Q1 2026, buying an estimated $238K and bringing the position to 1,056,218 shares worth $3.45M. The position accounts for ﹤0.01% of the portfolio, ranked #4048.

Goldman Sachs first reported a position in ACB in Q4 2018 and has held it in 29 quarters since. The position peaked at $10.3M in Q3 2025. 155 funds tracked by Wall St. Rank hold ACB as of Q1 2026.

  • Goldman Sachs held 1,056,218 shares of Aurora Cannabis worth $3.45M as of Q1 2026.
  • Goldman Sachs bought 63,087 Aurora Cannabis shares in Q1 2026, an estimated $238K.
  • Aurora Cannabis made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4048 holding.
  • Goldman Sachs first reported a position in Aurora Cannabis in Q4 2018 and has held it in 29 quarters since.
  • Goldman Sachs's Aurora Cannabis position peaked at $10.3M in Q3 2025.
  • 155 funds tracked by Wall St. Rank held Aurora Cannabis as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.